Patent Yard Sign in
Expired Australian patentAustralia

A combination of anti-erbB-2 monoclonal antibodies and method of using

AU 1993037733 · Applicant: Oncologix Inc

AusPat record

Overview

Drawings and full text

Its specification, documents and status are on IP Australia's AusPat.

Open the AusPat record

Read the whole patent

Listed from its IP Australia record in Patent Yard's archive of Australian patents past their term. Its claims, description and drawings are in the AusPat record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed October 21, 1992 and granted June 11, 1998. An Australian standard patent lasts 20 years from its date of patent, which is at most a year after this filing, so its term ended by October 21, 2013.
  • A pharmaceutical extension adds at most five years, so even that would have ended by October 21, 2018.
  • We check Australian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledOctober 21, 1992
GrantedJune 11, 1998
Term ended byOctober 21, 2013
Application numberAU 1993037733
Classification (IPC)C12N15/02 +2 more

Timeline

Timeline From IP Australia dates

1993199619992002200520082011Application filedOct 21, 1992Patent grantedJune 11, 1998Term ended byOct 21, 2013

Sources & verification

Everything on this page comes from the IP Australia record linked above. Data from IP Australia's IPGOD, licensed under CC BY 2.5 AU.